Insulet (PODD)
(Delayed Data from NSDQ)
$175.95 USD
+3.70 (2.15%)
Updated May 30, 2024 04:00 PM ET
After-Market: $175.94 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$175.95 USD
+3.70 (2.15%)
Updated May 30, 2024 04:00 PM ET
After-Market: $175.94 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Zacks News
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment
by Zacks Equity Research
Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.
Insulet (PODD) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Insulet (PODD) closed the most recent trading day at $319.91, moving +0.34% from the previous trading session.
3 Reasons Growth Investors Will Love Insulet (PODD)
by Zacks Equity Research
Insulet (PODD) possesses solid growth attributes, which could help it handily outperform the market.
Here's Why You Should Retain Amedisys (AMED) Stock for Now
by Zacks Equity Research
Amedisys's (AMED) share price is likely to grow following an impressive fourth-quarter 2022 performance and new partnerships.
Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Bruker Corporation (BRKR) outperforms the industry and the S&P 500 due to impressive quarterly results and segmental prospects.
Insulet (PODD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Insulet (PODD) closed at $312.90 in the latest trading session, marking a +0.52% move from the prior day.
Insulet (PODD) Benefits From Omnipod 5 Launch, Expansion
by Zacks Equity Research
Insulet (PODD) witnesses continued uptake of Omnipod through the U.S. pharmacy channel.
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
The Zacks Analyst Blog Highlights Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor
by Zacks Equity Research
Comfort Systems, Hershey, Wynn Resorts, Insulet and Lattice Semiconductor are included in this Analyst Blog.
Fed Policy Pause & Yellen's Assurance Buoy Wall Street: 5 Picks
by Tirthankar Chakraborty
Thanks to the Fed's willingness to pause its interest rate hikes, it's prudent for investors to place their bets on growth stocks like Comfort Systems USA (FIX), Hershey (HSY), Wynn Resorts (WYNN), Insulet (PODD), and Lattice Semiconductor (LSCC).
Insulet (PODD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Insulet (PODD) closed at $311.49, marking a -1.16% move from the previous day.
Insulet (PODD) Stock Moves -1.05%: What You Should Know
by Zacks Equity Research
In the latest trading session, Insulet (PODD) closed at $309.09, marking a -1.05% move from the previous day.
Insulet (PODD) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Insulet (PODD) closed at $312.36, marking a +1.45% move from the previous day.
3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
by Zacks Equity Research
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Company News for Mar 14, 2023
by Zacks Equity Research
Companies In The News Are: SGEN, PFE, PODD, SIVB, ILMN, PNC.
Insulet (PODD) Stock Moves -0.97%: What You Should Know
by Zacks Equity Research
Insulet (PODD) closed at $280.36 in the latest trading session, marking a -0.97% move from the prior day.
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
by Zacks Equity Research
Insulet (PODD) could produce exceptional returns because of its solid growth attributes.
Insulet (PODD) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Insulet (PODD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Teladoc Health (TDOC) Down 8.1% Since Q4 Earnings Release
by Zacks Equity Research
Teladoc Health's (TDOC) fourth-quarter results bear the brunt of escalating expenses. Management expects 2023 revenues within $2,550-$2,675 million, way higher than the 2022 figure.
Insulet (PODD) Q4 Earnings Beat Estimates, Margins Down
by Zacks Equity Research
Insulet's (PODD) Q4 performance benefits from record quarterly U.S. and Total Omnipod new customer starts.
Insulet (PODD) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Insulet (PODD) delivered earnings and revenue surprises of 129.17% and 11.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Insulet (PODD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Insulet (PODD) closed the most recent trading day at $298.61, moving +1.28% from the previous trading session.
Insulet (PODD) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
In Drug Delivery, Insulet (PODD) is expected to have faced higher manufacturing costs in Q4.
Insulet (PODD) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Insulet (PODD) closed at $289.36 in the latest trading session, marking a -0.96% move from the prior day.
Insulet (PODD) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Insulet (PODD) closed the most recent trading day at $290.53, moving +1.12% from the previous trading session.